**Question:** Inclusion body in oligodendroglia is a feature of which of the following:

A. Multiple Sclerosis
B. Alzheimer's Disease
C. Creutzfeldt-Jakob Disease
D. Huntington's Disease

**Core Concept:**
Inclusion bodies are abnormal protein aggregates found within cells, which can be a pathological feature in certain neurological disorders. In this question, we are considering inclusion bodies in oligodendroglia, which are the supportive cells in the central nervous system (CNS) that produce myelin. The correct understanding of these inclusion bodies is crucial for differentiating between the various diseases mentioned.

**Why the Correct Answer is Right:**
The correct answer is **C. Creutzfeldt-Jakob Disease (CJD)**. In CJD, the inclusion bodies in oligodendroglia are composed of the abnormal prion protein (PrPSc) which is responsible for the disease. This prion protein is derived from the normal cellular prion protein (PrPC) through a conformational change. The abnormal protein aggregates disrupt the normal function of oligodendroglia and lead to the characteristic neurological symptoms of CJD.

**Why Each Wrong Option is Incorrect:**

A. **Multiple Sclerosis (MS)**: In MS, oligodendroglia do not contain inclusion bodies. Instead, MS is characterized by demyelination and inflammation in the CNS, affecting the myelin sheath surrounding nerve fibers.

B. **Alzheimer's Disease (AD)**: In AD, inclusion bodies are observed in neurons, not oligodendroglia. AD is primarily associated with extracellular amyloid plaques and intracellular neurofibrillary tangles, which are made up of amyloid-beta and tau proteins, respectively.

D. **Huntington's Disease (HD)**: HD is caused by mutations in the huntingtin gene, resulting in an expanded CAG repeat in the huntingtin protein. Inclusion bodies in HD are found in neurons, not oligodendroglia.

**Clinical Pearl:**

Investigating the type of inclusion body in the context of a patient's clinical presentation and neurological examination findings is crucial for differentiating between the various neurological disorders. In this case, recognizing the presence of inclusion bodies in oligodendroglia helps in distinguishing between CJD, MS, AD, and HD. This knowledge is essential for accurate diagnosis, treatment options, and prognosis of patients with these neurological disorders.